The core activity of Kamfarma is the development and manufacturing of pharmaceutical active ingredients (APIs) and finished dosage forms (FDFs) in cooperation with global marketing partners. The company specializes in the development of complex generics and innovative medicines, particularly in the areas of oncology and specialized medicines. Kamfarma offers services such as API development, manufacturing and project management, as well as the development of finished dosage forms in various formulations. In addition, the company supports its partners in the clinical development, registration and marketing of medicines in various territories.